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Thirty-three Pseudomonas aeruginosa isolates, resistant to one or more
β-lactams, were included in this study. Identiﬁcation of tested strains was conﬁrmed
using MALDI-TOF/MS. Phenotypic and genotypic β-lactamase patterns were inves-
tigated. Most of the isolates were resistant to carbapenems (32 out of 33) and to the
extended-spectrum cephalosporins (ESC) (30 out of 33). Phenotypically, the produc-
tion of extended-spectrum beta-lactamase (ESBL), metallo-β-lactamases (MBL), and
carbapenemases was detected in 10, 23, and 9 isolates, respectively. However, AmpC
hyperproduction was not phenotypically detected among all isolates. Genotypically,
ESBL and MBL encoding genes were detected in 23 and 27 isolates, respectively.
Altogether 27 strains were detected as blaVIM positive and 16 strains carried blaOXA-10
gene. To the best of our knowledge, this is the ﬁrst report of P. aeruginosa clinical
isolates harboring blaVEB together with blaGES in Egypt, where 5 of our 30 ESC-
resistant isolates showed this genotype. Our results conﬁrmed that resistance of
P. aeruginosa isolates to β-lactam antibiotics is mediated via multiple β-lactamases
belonging to different molecular classes. To the best of our knowledge, this is the ﬁrst
report of blaVEB among P. aeruginosa clinical isolates from Egypt. Ten isolates
harbored blaVEB and ﬁve of them co-harbored blaVEB together with blaGES, blaVIM,
and blaOXA-10.
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Introduction
Pseudomonas aeruginosa is a non-fermentative, Gram-negative bacteria
that is widely disseminated in nature. It has a remarkable ability to survive on
various surfaces in both community and hospital settings. Thus, P. aeruginosa has
a signiﬁcant role in nosocomial infections being responsible for a wide variety of
infections including wound and burn infections, respiratory tract infections,
urinary tract infections, and blood stream infections [1].
P. aeruginosa demonstrates intrinsic resistance to several antimicrobial
agents due to the reduced permeability of its outer membrane. This natural
resistance evolves against penicillin G, aminopenicillin, and cephalosporins
of the ﬁrst and second generations. Therefore, treatment of infections caused
by P. aeruginosa is usually limited to only few antimicrobial agents. These
agents include extended-spectrum penicillins, such as ticarcillin and piperacillin
(PRL), some third-generation cephalosporins such as ceftazidime (CAZ), and all
the fourth-generation cephalosporins, carbapenems, and monobactams. Unfor-
tunately, there is a rising resistance against these agents causing a critical
challenge to choose the effective antimicrobial therapy for optimized clinical
outcome [2, 3].
Among the different mechanisms that mediate β-lactam resistance, antibi-
otic cleavage by β-lactamase enzymes is considered to be of major importance.
There are two classiﬁcation schemes for β-lactamases that are generally adopted.
The ﬁrst one depends on similarity in the amino acid sequence, whereas the other
depends on the functionality [4, 5]. According to the amino acid sequence
similarity, Ambler [6, 7] divided β-lactamases into four classes, namely A, B, C,
and D. All classes possess serine in their active site except for class B, which
requires zinc ion to be active. Therefore, class B is commonly known as metallo-
β-lactamases (MBL). The scheme that depends on functionality separates
β-lactamases into three groups, namely 1, 2, and 3. Group 1 consists of
cephalosporinases, which correspond to class C in Ambler classiﬁcation. Group
2 consists of serine β-lactamases that include classes A and D of the Ambler
classiﬁcation. Group 3 consists of MBL and they correspond to class B in
Ambler classiﬁcation. Then, each of these three groups is divided into various
subgroups [5]. To the best of our knowledge, this is the ﬁrst study in Egypt
to tackle all classes of β-lactamases among P. aeruginosa and to report the
co-existence of VEB and GES β-lactamases along with other β-lactamases. Here,
we determined the phenotypic resistance patterns to β-lactam antibiotics and
identiﬁed the genetic determinants responsible for β-lactamases-induced resis-
tance among P. aeruginosa clinical isolates resistant to one or more of the
β-lactams.
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Material and Methods
All culture media and antibiotic disks used in this study were purchased
from Oxoid (Cambridge, UK).
Collection of clinical isolates
A total of 33 P. aeruginosa isolates resistant to one or more β-lactams were
collected during the period from September 2014 to June 2015. They were
obtained from different clinical samples submitted to the Microbiology Depart-
ment, Medical Research Institute, Alexandria University. The identiﬁcation of
P. aeruginosa isolates was conﬁrmed using matrix-assisted laser desorption
ionization–time of ﬂight mass spectrometry (MALDI-TOF/MS; Bruker,
Billerica, MA, USA).
Antimicrobial susceptibility
Kirby–Bauer method [8] was used for the antimicrobial susceptibility testing
of P. aeruginosa strains on Mueller–Hinton agar plates. β-lactam antibiotics were
chosen according to the CLSI recommendations [9]. The disks used were CAZ,
cefepime (CFP), PRL, PRL/tazobactam (TZP), aztreonam (ATM), imipenem
(IPM), and meropenem (MEM). The sizes of the inhibition zones were interpreted
according to CLSI M100-S27 and the organisms were reported as sensitive,
intermediate, or resistant to the agents that have been tested.
β-lactamases phenotypic characterization
Strains that were found to be resistant to CAZ and/or CFP were further
screened for the presence of extended-spectrum beta-lactamase (ESBL) and
AmpC β-lactamases hyperproduction, whereas those resistant to IPM and/or
MEM were further screened for the presence of carbapenemases and MBL.
Screening for ESBL production
P. aeruginosa isolates resistant to CAZ and/or CFP were investigated for
ESBL production using combined disk method [10]. Disks containing CAZ
(30 μg) alone and in combination with clavulanic acid (30/10 μg) were used.
They were placed far apart on a Mueller–Hinton agar plate containing 400 μg of
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3-aminophenyl boronic acid (APB; Arcos Organics, New Jersey, USA) and
inoculated with 0.5 McFarland suspension of the tested strain. After overnight
incubation at 35 °C, ESBL-producing strains demonstrated at least 5-mm increase
in the inhibition zone in presence of clavulanic acid [10].
Screening of AmpC hyperproduction
P. aeruginosa isolates resistant to CAZ and/or CFP were investigated for
AmpC hyperproduction using combined disk method, as described by Coudron
et al. [11]. Brieﬂy, a disk containing 30 μg of CAZ and another one containing
30 μg of CAZ in combination with 600 μg APB were placed far apart on the
surface of Mueller–Hinton agar plates inoculated with 0.5 McFarland suspension
of the tested strain and then incubated overnight at 35 °C. Strains that showed at
least 5-mm increase in the inhibition zone in the presence of APB were considered
to be AmpC hyperproducers [11].
Screening for carbapenemase production
P. aeruginosa strains resistant to one or more of the carbapenems were
screened for carbapenemase production by modiﬁed Hodge test (MHT) using
carbapenem-susceptible Klebsiella pneumoniae as the indicator organism [12].
Mueller–Hinton agar plate was inoculated with 0.5 McFarland suspension of
the indicator strain. Then, two disks containing IPM (10 μg) and MEM (10 μg)
were placed on the agar plate away from each other. Heavy inoculum of the test
strain was streaked onto the Mueller–Hinton agar plate in a straight line from the
edge of one disk to the plate periphery. Carbapenemase production induces a
cloverleaf-shaped indentation of growth of the indicator strain after overnight
incubation [12].
Screening for MBL production
P. aeruginosa strains resistant to one or more of the carbapenems were
screened for MBL production using combined disk method, as described by Yong
et al. [13]. One disk containing IPM (10 μg) and one containing IPM and EDTA
(10/930 μg) were placed on a Mueller–Hinton agar plate inoculated with 0.5
McFarland suspension of the tested strain and incubated overnight at 35 °C. MBL-
producing strains showed 7 mm or greater increase between the inhibition zone
around IPM disk alone and that around IPM–EDTA disk [13].
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Detection of β-lactamase encoding genes
Genotypic detection of different β-lactamase genes belonging to ESBL,
MBL, and OXA classes was performed using polymerase chain reaction (PCR).
All primers used in this study are listed in Supplementary Tables I–III. The primers
were purchased from Biosearch Technologies (Novato, CA, USA). The PCR
Master mix MyTaq HS Red Mix was supplied by BioLine (London, UK). PCR
ampliﬁcation of the extracted DNA was carried out on Veriti Thermal Cycler
(Applied Biosystems, CA, USA).
Bacterial DNA was extracted by boiling method; shortly 3–4 colonies were
suspended in sterile Tris-EDTA buffer to make a heavy suspension. The suspen-
sion was incubated in a boiling water bath for 15 min followed by rapid cooling on
ice and centrifugation. The supernatant was used as a DNA template. PCR was
performed in a total volume of 25 μl including 12.5 μl 2X MyTaq HS Red Mix,
10 picomoles of each primer, and 0.5 μl DNA extract. A negative control was
prepared by the addition of the same contents to the tube without DNA extract.
Results
Identiﬁcation and antimicrobial susceptibility
The identiﬁcation of 33 isolates included in this study as P. aeruginosa was
conﬁrmed using MALDI-TOF/MS. Twelve (36.4%) out of them were obtained
from wound swabs, 11 (33.3%) from urine samples, 7 (21.2%) from respiratory
tract infections, and 3 (9.1%) from pus syringes.
Antibiotic susceptibility testing using Kirby–Bauer method showed that 32
out of 33 P. aeruginosa isolates were resistant to IPM and/or MEM, with only one
strain sensitive to both. Thirty out of 33 P. aeruginosa isolates were resistant to CAZ
and/or CFP. The detailed results for the disk diffusion test are shown in Table I.
Detection of ESBL
Phenotypic detection of ESBL was carried out using combined disk method;
only 10 (33.3%) P. aeruginosa isolates showed ESBL production.
Detection of ESBL genes
The results of the detection of blaTEM, blaSHV, blaCTX-M, blaPSE-1, blaGES,
blaPER, and blaVEB genes among 30 P. aeruginosa strains, which were resistant to
CAZ and/or CFP, are shown in Table II.
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Detection of AmpC hyperproduction
Phenotypic detection of AmpC hyperproduction was carried out on
30 P. aeruginosa strains, which were resistant to CAZ and/or CFP, using APB
combined disk method. However, none of our 30 strains was an AmpC
hyperproducer.
Detection of carbapenemases
Thirty-two P. aeruginosa strains resistant to IPM and/or MEM were
phenotypically tested for the presence of carbapenemases using MHT. Only 9
out of 32 strains were positive.
Detection of MBL
Thirty-two P. aeruginosa strains resistant to IPM and/or MEM were
phenotypically tested for the presence of MBL using combined disk method.
Twenty-three out of 32 strains were positive determined using IPM–EDTA
combined disk method.
Table I. Resistance of the 33 P. aeruginosa isolates to different β-lactam antibiotics
Antibiotic
Resistance Intermediate Sensitive
N % N % N %
CAZ 29 87.88 1 3.03 3 9.09
CFP 30 90.91 2 6.06 1 3.03
PRL 14 42.42 17 51.52 2 6.06
TZP 14 42.42 15 45.46 4 12.12
ATM 7 21.21 22 66.67 4 12.12
IPM 31 93.94 1 3.03 1 3.03
MEM 31 93.94 0 0 2 6.06
Note: CAZ: ceftazidime; CFP: cefepime; PRL: piperacillin; TZP: piperacillin/tazobactam; ATM: aztreonam;
IPM: imipenem; MEM: meropenem.
Table II. ESBL gene detection among 30 P. aeruginosa isolates
ESBL genes blaTEM blaSHV blaCTX-M blaPER blaVEB blaPSE-1 blaGES
Positive 9 (30%) 1 (3.3%) 4 (13.3%) 3 (10%) 10 (33.3%) 2 (6.6%) 15 (50%)
Negative 21 (70%) 29 (96.7%) 26 (86.7%) 27 (90%) 20 (66.7%) 28 (93.3%) 15 (50%)
Note: ESBL: extended-spectrum beta-lactamase.
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Detection of MBL genes
Thirty-two carbapenem-resistant P. aeruginosa were investigated for the
presence of the following genes: blaVIM, blaIMP, blaSPM-1, blaNDM-1, and blaGIM.
blaVIM was the only detected gene in 27 (84.4%) isolates (Table III).
Detection of OXA genes
Thirty-three P. aeruginosa strains were screened for the presence of blaOXA-
1, blaOXA-2, and blaOXA-10 genes. Only blaOXA-10 gene was detected among
16 (48.5%) strains, as shown in Table IV.
Distribution of β-lactamases genes among our clinical isolates
In this study, 11 (33.3%) out of 33 P. aeruginosa strains harbored 3–5
genes belonging to 3 β-lactamase classes: ESBL (class A), MBL (class B), and
OXA β-lactamases (class D). Whereas, 8 (24.2%) harbored 2–3 genes belonging
to 2 β-lactamase classes A and B. Five (15.2%) isolates harbored
one gene belonging to the MBL class, as shown in Table V. Interestingly, two
isolates did not harbor any of the tested β-lactamase encoding genes; one of them
was resistant to carbapenems, whereas the other was resistant to all tested
β-lactams.
Table III. Detection of MBL genes among 32 carbapenem-resistant P. aeruginosa
MBL genes blaIMP blaVIM blaNDM-1 blaSPM-1 blaGIM-1
Positive 0 (0%) 27 (84.4%) 0 (0%) 0 (0%) 0 (0%)
Negative 32 (100%) 5 (15.6%) 32 (100%) 32 (100%) 32 (100%)
Note: MBL: metallo-β-lactamase.
Table IV. Detection of OXA genes among 33 P. aeruginosa isolates
OXA genes blaOXA-1 blaOXA-2 blaOXA-10
Positive 0 (0%) 0 (0%) 16 (48.5%)
Negative 33 (100%) 33 (100%) 17 (51.5%)
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Discussion
β-lactams that are usually used for treatment of P. aeruginosa infections
include extended-spectrum penicillins, monobactams extended-spectrum cepha-
losporins (ESC), and carbapenems [3].
In this study, most of the P. aeruginosa isolates were resistant to both
carbapenems (93.94%) and ESC (90.91%); on the other hand, a much lower
resistance was observed against ATM, PRL, and TZP (21.21%, 42.42%, and
42.42%, respectively).
Detection of ESBL genes was carried out for 30 P. aeruginosa isolates
resistant to the ESC. blaGES was detected in 15 (50%) of the isolates, followed by
blaVEB in 10 (33%) and blaTEM in 9 (30%). To the best of our knowledge, this is
the ﬁrst study to report P. aeruginosa clinical isolates co-harboring blaGES and
blaVEB in Egypt. Lower detection rate was observed for blaPER, which was
detected in 3 (10%), blaPSE-1 in 2 (6.6%), and blaSHV in 1 (3.3%). Seven isolates
had three ESBL genes and six isolates had two genes. blaGES was detected alone in
eight isolates, whereas no ESBL genes were detected in six isolates.
ESBL genes were detected in 24 (80%) out of 30 ESC-resistant
P. aeruginosa isolates. However, according to the phenotypic method used in
Table V. Distribution of β-lactamase genes and classes among 33 P. aeruginosa strains
No. of isolates β-lactamase genes
Number of
genes
β-lactamase
molecular class
3 blaVEB, blaTEM, blaGES, blaVIM, and blaOXA-10 5 A, B, and D
1 blaPER, blaVEB, blaPSE-1, blaVIM, and blaOXA-10 5 A, B, and D
1 blaVEB, blaPSE-1, blaGES, blaVIM, and blaOXA-10 5 A, B, and D
1 blaPER, blaVEB, blaCTX-M, blaVIM, and blaOXA-10 5 A, B, and D
1 blaTEM, blaVEB, blaCTX-M, blaVIM, and blaOXA-10 5 A, B, and D
1 blaTEM, blaGES, blaVIM, and blaOXA-10 4 A, B, and D
1 blaVEB, blaGES, blaVIM, and blaOXA-10 4 A, B, and D
1 blaVEB, blaCTX-M, blaVIM, and blaOXA-10 4 A, B, and D
1 blaVEB, blaVIM, and blaOXA-10 3 A, B, and D
1 blaPER, blaTEM, and blaVIM 3 A and B
1 blaTEM, blaGES, and blaVIM 3 A and B
1 blaSHV and blaVIM 2 A and B
1 blaTEM and blaVIM 2 A and B
2 blaGES and blaOXA-10 2 A and D
4 blaGES and blaVIM 2 A and B
2 blaVIM and blaOXA-10 2 B and D
2 blaTEM and blaCTX-M 2 A
1 blaGES 1 A
5 blaVIM 1 B
2 No genes 0 –
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this study, ESBL production was detected in 10 (33.3%) out of 30 P. aeruginosa
strains resistant to the third- and fourth-generation cephalosporins. This conﬁrms
that the phenotypic detection of ESBL, which is based on the use of clavulanic
acid as an inhibitor, is unreliable with a low sensitivity (37.5%).
Jiang et al. [14], Zafer et al. [10], and Poulou et al. [15] supported previous
implication that the ongoing ESBL detection methods are uncertain in
P. aeruginosa, as there is no standardized method for the detection of ESBLs
in P. aeruginosa.
In this study, only blaVIM of the MBL genes was detected among
our isolates. It was detected in 27 (84.4%) out of 32 carbapenem-resistant
P. aeruginosa isolates. On the other hand, the rest of the tested genes such as
blaIMP, blaSPM-1, blaGIM-1, and blaNDM-1 genes were not detected among our
isolates.
In this study, 23 (71.9%) out of 32 carbapenem-resistant P. aeruginosa
isolates were phenotypically MBL-positive. Four (17.4%) out of 23 phenotypi-
cally MBL-positive isolates did not harbor any of the tested MBL genes.
Genotypic screening of 32 P. aeruginosa isolates showed that 27 (84.4%)
of them harbored blaVIM gene of which 8 (29.6%) were phenotypically
MBL-negative. On the other hand, four P. aeruginosa isolates showed enlarged
zone in absence of genes encoding for MBL. False-positive and false-negative
phenotypic detection of MBL has been observed with a sensitivity and speciﬁcity
of 70.37% and 20.0%, respectively.
Similar ﬁndings were reported by Gerges and Amin [16] who found that
eight out of their isolates, which were phenotypically MBL-negative, carried one
or more MBL genes.
Aghamiri et al. [17] reported similar results as 11 isolates that were
phenotypically MBL-negative carried MBL genes as detected by PCR.
Chu et al. [18] reported that methods using EDTA are highly sensitive but
not speciﬁc when analyzing MBL production, as this method may lead to
false-positive results. This was conﬁrmed by Marra et al. [19] who reported a
false-positive detection rate (69.6%) with EDTA.
Franco et al. [20] stated that EDTA has a bactericidal activity, which causes
a synergistic effect with carbapenems resulting in increased inhibition zones. Chu
et al. [18] reported that methods using EDTA are highly sensitive but not speciﬁc
suggesting that caution must be taken when analyzing MBL production, as
this method may lead to false-positive results. In addition, EDTA may affect
the membrane permeability, which causes increased susceptibility to carbapenems
and other antimicrobial agents. Thereby, it causes false reading of the MBL tests
involving EDTA [21]. It is noteworthy that phenotypic tests for MBL in
P. aeruginosa have not yet been standardized [20, 22].
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CLSI recommended that Enterobacteriaceae with increased inhibitory
concentrations (MICs) or decreased inhibition zones should be screened for
carbapenemases production using MHT. It should be noted that P. aeruginosa
is not included in that recommendation in spite of the rising carbapenem resistance
among its isolates [9].
Pasteran et al. [12] reported that, with the MHT, a high proportion of
indeterminate results were observed in 22% and 43% of carbapenemase producers
and non-producers, respectively, with a sensitivity and speciﬁcity of 78% and
57%, respectively.
In P. aeruginosa, AmpC β-lactamases are an inducible chromosomally
encoded enzyme. Normally, P. aeruginosa strains produce low levels of AmpC
β-lactamases when an inducing β-lactam is lacking. In absence of any other
resistance mechanism, these strains may be susceptible to broad spectrum
penicillins, penicillin-inhibitor combinations, cephalosporins, and carbapenems.
However, when ampC is derepressed, it results in high levels of ampC expression,
thereby resulting in resistance to practically all β-lactams [1].
Screening for AmpC induction relies on the disk approximation (D-test)
assay using cefoxitin/ceftazidime (FOX/CAZ) [23]. In this study, induction of
AmpC using D-test assay was not possible since all of our 30 P. aeruginosa
isolates were resistant to CAZ.
In this study, a combined disk test using CAZ/APB was used instead.
Accordingly, none of our 30 ESC-resistant isolates was considered as AmpC
hyperproducer, since the addition of APB did not result in the enlargement of the
inhibitory zone diameter around the disk (CAZ/APB) by ≥5 mm.
Class D β-lactamases are also called OXA enzymes (oxacillinases) as they
favorably hydrolyze oxacillin and cloxacillin rather than benzylpenicillin. These
enzymes are generally narrow spectrum, and induce resistance to narrow spectrum
cephalosporins, aminopenicillins, as well as carboxypenicillins [4].
In this study, blaOXA-10 gene was detected among 16 (48.5%) of 33
P. aeruginosa strains. Our results agree with Zafer et al. [10] who reported that
the prevalence of blaOXA-10 was 41.7% out of their 122 P. aeruginosa Egyptian
isolates.
To the best of our knowledge, this is the ﬁrst time to detect blaVEB in
P. aeruginosa clinical isolates from Egypt. blaVEB was found in 10 of our isolates
together with other β-lactamase genes. Five of the isolates harbored blaVEB with
blaGES, blaVIM, and blaOXA-10, whereas the other ﬁve isolates harbored blaVEB,
blaVIM, and blaOXA-10.
According to our results, resistance of P. aeruginosa isolates to β-lactam
antibiotics was found to be mainly mediated via multiple β-lactamases belonging
to different molecular classes. Twenty-three isolates (69.7%) harbored 2–5 genes
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belonging to more than one β-lactamase class (2–3 classes). Only six isolates
harbored a single gene belonging to a single β-lactamase class (A or B).
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